Short report of the cost issues for switching from the Enzyme-Immuno Assay (EIA) test to Nucleic Acid Amplification Test (NAAT) for diagnosis of Chlamydia Trachomatis, and the introduction of an opportunistic screening programme in Norfolk

E Wilson

Short report of the cost issues for switching from the Enzyme-Immuno Assay (EIA) test to Nucleic Acid Amplification Test (NAAT) for diagnosis of Chlamydia Trachomatis, and the introduction of an opportunistic screening programme in Norfolk

Research output: Working paper

Original language	English
Publication status	Published - 2003

Cite this

@techreport{d9edb3f6081640e78d115e7be5a7b94b,

title = "Short report of the cost issues for switching from the Enzyme-Immuno Assay (EIA) test to Nucleic Acid Amplification Test (NAAT) for diagnosis of Chlamydia Trachomatis, and the introduction of an opportunistic screening programme in Norfolk",

author = "E Wilson",

year = "2003",

language = "English",

type = "WorkingPaper",

}

TY - UNPB

T1 - Short report of the cost issues for switching from the Enzyme-Immuno Assay (EIA) test to Nucleic Acid Amplification Test (NAAT) for diagnosis of Chlamydia Trachomatis, and the introduction of an opportunistic screening programme in Norfolk

AU - Wilson, E

PY - 2003

Y1 - 2003

M3 - Working paper

BT - Short report of the cost issues for switching from the Enzyme-Immuno Assay (EIA) test to Nucleic Acid Amplification Test (NAAT) for diagnosis of Chlamydia Trachomatis, and the introduction of an opportunistic screening programme in Norfolk

ER -